Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With t… (NCT07389473) | Clinical Trial Compass
RecruitingNot Applicable
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
United States50 participantsStarted 2024-04-17
Plain-language summary
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged between 18 and 65, having given written informed consent to participate in the research trial.
* Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.
* Normal or corrected to normal vision using either glasses or contact lenses, or surgery.
Exclusion Criteria:
* Enrolled in, or participated in another clinical trial within 30 days before the study
* Having a prosthetic eye, missing eye, or wearer of an eye patch LASIK or other eye surgery within the prior 21 days.
* Had your eyes dilated by a medical doctor in the previous 24 hours.
* Photosensitive epilepsy
* Diagnosed with clinical blindness
* Medical Conditions: Participants with medical conditions or medications that could significantly affect cognitive and motor functions are excluded. Participants with conditions such as Glaucoma, macular degeneration, cataracts, lazy eye (amblyopia), or optic neuritis, or genetic anisocoria (unequal pupil size) will be excluded.
* Current or past head inject/ traumatic brain injury (TBI)
* Pregnancy: Pregnant individuals will be excluded from the study due to the potential risks associated with psychiatric medications.
* History of Severe Motion Sickness: Participants with a history of severe motion sickness in VR environments may be excluded, as they may not tolerate the VR headset well.
* Potential participants who are unable to provide consent for the study.
What they're measuring
1
Collection of Ophthalmic Data
Timeframe: 1 Day
Trial details
NCT IDNCT07389473
SponsorGaize
Sponsor typeINDUSTRY
Study typeOBSERVATIONAL
Primary completion2027-12
Contact for this trial
Apurva Raje Research Coordinator / Principal Investigator, BA